Last reviewed · How we verify

NCT04220138

Anterior Chamber Illumination in Cataract Surgery for Eyes With Poor Red Reflex

Completed NA Last updated 9 January 2020
What this trial tests

NA trial testing Anterior chamber illumination in cataract surgery in Cataract Senile in 53 participants. Completed in 1 January 2020.

Timeline
1 January 2019
Primary endpoint
1 July 2019
1 January 2020

Quick facts

Lead sponsorUniversity of Alexandria
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment53
Start date1 January 2019
Primary completion1 July 2019
Estimated completion1 January 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

University of Alexandria

Who can join

18 and older, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With a poor red reflex, it is difficult to see the anterior capsule and continuous curvilinear capsulorhexis (CCC) margin, sometimes resulting in decentered CCC or radial tearing of the anterior capsule. In addition, other complications, such as rupture of the posterior capsule, dropping of the lens nucleus, or zonular dialysis, can occur during phacoemulsification because of poor visualization of the posterior capsule. These complications also increase the time of surgery and may affect the results of the vitrectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cataract Senile

Currently open trials in the same condition.

Other University of Alexandria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04220138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing